Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

Share · CNE100005139 (XSHG)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Beijing Sun-Novo Pharmaceutical Research Co., Ltd.
No Price
Closing Price XSHG 29.04.2026: 58,56 CNY
29.04.2026 07:00
Current Prices from Beijing Sun-Novo Pharmaceutical Research Co., Ltd.
ExchangeTickerCurrencyLast TradePriceDaily Change
XSHG: SSE
SSE
688621.SS
CNY
29.04.2026 07:00
58,56 CNY
0,23 CNY
+0,39 %
Share Float & Liquidity
Free Float 58,97 %
Shares Float 66,05 M
Shares Outstanding 112 M
Company Profile for Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Share
Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of chemical drugs and peptide drugs in China. The company offers small molecule chemical generic drugs; peptide products; and drugs for indications, such as impetigo, acne, renal anemia, chronic kidney disease dialysis patient hyper parathyroid hormone, analgesia, and other symptoms. It also provides packaging material compatibility test, impurity research, extract research, migration research, safety evaluation, and other research services; consistency evaluation services; clinical research services; registration consulting and agency services; and range of pharmacokinetics-pharmacodynamics and GLP bioanalysis services, including pharmacokinetic bioanalysis, immunogenic biology analysis, pharmacodynamics, and biomarker bioanalysis services. The company was founded in 2009 and is based in Beijing, China.

Company Data

Name Beijing Sun-Novo Pharmaceutical Research Co., Ltd.
Company Beijing Sun-Novo Pharmaceutical Research Co., Ltd.
Website https://www.sun-novo.com
Primary Exchange XSHG SSE
ISIN CNE100005139
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Yujing Liu
Market Capitalization 7 Mrd.
Country China
Currency CNY
Employees 1,6 T
Address Building 7, 102200 Beijing
IPO Date 2021-06-21
Dividends from 'Beijing Sun-Novo Pharmaceutical Research Co., Ltd.'
Ex-Date Dividend per Share
11.06.2025 0,16 CNY
09.07.2024 0,17 CNY
12.05.2023 0,84 CNY
15.04.2022 0,27 CNY

Stock Splits

Date Split
12.05.2023 7:5

Ticker Symbols

Name Symbol
SSE 688621.SS
More Shares
Investors who hold Beijing Sun-Novo Pharmaceutical Research Co., Ltd. also have the following shares in their portfolio:
DZ BANK      CLN E.10483
DZ BANK CLN E.10483 Bond
OP CORPORATE BANK PLC 3.086% INSTRS 23/08/27
OP CORPORATE BANK PLC 3.086% INSTRS 23/08/27 Bond